Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Stomach Neoplasms × titanium silicide × Clear all

Phase

Status

Sponsor Class

OTHER 15 INDUSTRY 6 UNKNOWN 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Cancer 1

Interventions

Oxaliplatin 9 Fluorouracil 6 Irinotecan 5 Docetaxel 5 tislelizumab 4 S 1 (combination) 4 Paclitaxel 4 Endoscopic Mucosal Resection 4 Capecitabine 4 XELOX 3 Levoleucovorin 3 Folfox protocol 3 sintilimab 2 apatinib 2 Proton Pump Inhibitors 2 Laparoscopy 2 Gastroenterostomy 2 Gastrectomy 2 vactosertib 1 titanium silicide 1 pembrolizumab 1 lenvatinib 1 durvalumab 1 anlotinib 1 Tranexamic Acid 1 Tomography, X-Ray Computed 1 Surgical Procedures, Operative 1 Standard of Care 1 Robotic Surgical Procedures 1 Ramucirumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00512681 2009-09-18

TIROX2

National Cancer Center, Korea

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡